BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 17160805)

  • 1. Radiofrequency ablation of unresectable hepatic tumors.
    Geyik S; Akhan O; Abbasoğlu O; Akinci D; Ozkan OS; Hamaloğlu E; Ozmen M
    Diagn Interv Radiol; 2006 Dec; 12(4):195-200. PubMed ID: 17160805
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Radiofrequency ablation for unresectable tumors of the liver.
    Howard JH; Tzeng CW; Smith JK; Eckhoff DE; Bynon JS; Wang T; Arnoletti JP; Heslin MJ
    Am Surg; 2008 Jul; 74(7):594-600; discussion 600-1. PubMed ID: 18646476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient factors affecting thermal lesion size with an impedance-based radiofrequency ablation system.
    Glaiberman CB; Pilgram TK; Brown DB
    J Vasc Interv Radiol; 2005 Oct; 16(10):1341-8. PubMed ID: 16221905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Computed tomography-guided radiofrequency ablation of hepatocellular carcinoma: treatment efficacy and complications.
    Laspas F; Sotiropoulou E; Mylona S; Manataki A; Tsagouli P; Tsangaridou I; Thanos L
    J Gastrointestin Liver Dis; 2009 Sep; 18(3):323-8. PubMed ID: 19795027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term outcomes after hepatic resection combined with radiofrequency ablation for initially unresectable multiple and bilobar liver malignancies.
    Qiu J; Chen S; Wu H
    J Surg Res; 2014 May; 188(1):14-20. PubMed ID: 24387841
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intraoperative radiofrequency ablation (RFA) for irresectable liver malignancies.
    Tepel J; Hinz S; Klomp HJ; Kapischke M; Kremer B
    Eur J Surg Oncol; 2004 Jun; 30(5):551-5. PubMed ID: 15135485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overcoming the heat-sink phenomenon: successful radiofrequency thermal ablation of liver tumors in contact with blood vessels.
    Thanos L; Mylona S; Galani P; Pomoni M; Pomoni A; Koskinas I
    Diagn Interv Radiol; 2008 Mar; 14(1):51-6. PubMed ID: 18306146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long-term survival after radiofrequency ablation of complex unresectable liver tumors.
    Amersi FF; McElrath-Garza A; Ahmad A; Zogakis T; Allegra DP; Krasne R; Bilchik AJ
    Arch Surg; 2006 Jun; 141(6):581-7; discussion 587-8. PubMed ID: 16785359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for the local recurrence of hepatocellular carcinoma after a single session of percutaneous radiofrequency ablation.
    Hori T; Nagata K; Hasuike S; Onaga M; Motoda M; Moriuchi A; Iwakiri H; Uto H; Kato J; Ido A; Hayashi K; Tsubouchi H
    J Gastroenterol; 2003; 38(10):977-81. PubMed ID: 14614605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Radiofrequency ablation for the management of liver tumors.
    Bachar GN; Greif F; Mor E; Tur-Kaspa R; Belenky A
    Isr Med Assoc J; 2003 Jul; 5(7):496-500. PubMed ID: 12901246
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Locoregional recurrences are frequent after radiofrequency ablation for hepatocellular carcinoma.
    Harrison LE; Koneru B; Baramipour P; Fisher A; Barone A; Wilson D; Dela Torre A; Cho KC; Contractor D; Korogodsky M
    J Am Coll Surg; 2003 Nov; 197(5):759-64. PubMed ID: 14585410
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Histologic evaluation and treatment outcome after sequential radiofrequency ablation and hepatic resection for primary and metastatic tumors.
    Hoffman AL; Wu SS; Obaid AK; French SW; Lois J; McMonigle M; Ramos HC; Sher LS; Lopez RR
    Am Surg; 2002 Dec; 68(12):1038-43. PubMed ID: 12516804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous radiofrequency ablation and transcatheter arterial chemoembolization for hypervascular hepatocellular carcinoma: rate and risk factors for local recurrence.
    Murakami T; Ishimaru H; Sakamoto I; Uetani M; Matsuoka Y; Daikoku M; Honda S; Koshiishi T; Fujimoto T
    Cardiovasc Intervent Radiol; 2007; 30(4):696-704. PubMed ID: 17497071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Laparoscopic radiofrequency ablation of unresectable liver malignancies: feasibility and clinical outcome.
    Topal B; Aerts R; Penninckx F
    Surg Laparosc Endosc Percutan Tech; 2003 Feb; 13(1):11-5. PubMed ID: 12598751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Percutaneous radiofrequency ablation of malignant liver tumors with ultrasound and CT fusion imaging guidance.
    Xu ZF; Xie XY; Kuang M; Liu GJ; Chen LD; Zheng YL; Lu MD
    J Clin Ultrasound; 2014; 42(6):321-30. PubMed ID: 24615771
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radiofrequency ablation of recurrent hepatocellular carcinoma after hepatectomy].
    Yang W; Chen MH; Yan K; Gao W; Yin SS; Wang YB; Zhang XP; Xing BC; Huang XF
    Zhonghua Wai Ke Za Zhi; 2005 Aug; 43(15):980-4. PubMed ID: 16194353
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Efficacy of radiofrequency ablation to treat advanced hepatocellular carcinoma].
    Wu J; Chen MH; Yang W; Wu W; Yan K
    Zhonghua Gan Zang Bing Za Zhi; 2012 Apr; 20(4):256-60. PubMed ID: 22964144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is percutaneous radiofrequency thermal ablation of hepatocellular carcinoma a safe procedure?
    Zavaglia C; Corso R; Rampoldi A; Vinci M; Belli LS; Vangeli M; Solcia M; Castoldi C; Prisco C; Vanzulli A; Pinzello G
    Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):196-201. PubMed ID: 18301300
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical short-term results of radiofrequency ablation in primary and secondary liver tumors.
    Jiao LR; Hansen PD; Havlik R; Mitry RR; Pignatelli M; Habib N
    Am J Surg; 1999 Apr; 177(4):303-6. PubMed ID: 10326848
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of radiofrequency ablation in the treatment of primary and metastatic tumours of the liver: initial lessons learned.
    Choy PY; Koea J; McCall J; Holden A; Osbourne M
    N Z Med J; 2002 Aug; 115(1159):U128. PubMed ID: 12362172
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.